123 related articles for article (PubMed ID: 228594)
1. RMI 15,731 (1-[5-tetradecyloxy-2-furanyl]-ethanone), a new antirhinovirus compound.
Ash RJ; Parker RA; Hagan AC; Mayer GD
Antimicrob Agents Chemother; 1979 Sep; 16(3):301-5. PubMed ID: 228594
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime.
Ninomiya Y; Aoyama M; Umeda I; Suhara Y; Ishitsuka H
Antimicrob Agents Chemother; 1985 Apr; 27(4):595-9. PubMed ID: 2988431
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.
Conti C; Tomao P; Genovese D; Desideri N; Stein ML; Orsi N
Antimicrob Agents Chemother; 1992 Jan; 36(1):95-9. PubMed ID: 1317152
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of drug resistance to new antirhinovirus agents.
Ishitsuka H; Ninomiya Y; Suhara Y
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():11-8. PubMed ID: 3025150
[TBL] [Abstract][Full Text] [Related]
5. Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.
Ishitsuka H; Ninomiya YT; Ohsawa C; Fujiu M; Suhara Y
Antimicrob Agents Chemother; 1982 Oct; 22(4):617-21. PubMed ID: 6295261
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of R 61837, a new antirhinovirus compound.
Andries K; Dewindt B; De Brabander M; Stokbroekx R; Janssen PA
Arch Virol; 1988; 101(3-4):155-67. PubMed ID: 2845889
[TBL] [Abstract][Full Text] [Related]
7. Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers.
Zerial A; Werner GH; Phillpotts RJ; Willmann JS; Higgins PG; Tyrrell DA
Antimicrob Agents Chemother; 1985 May; 27(5):846-50. PubMed ID: 2990329
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones.
Desideri N; Mastromarino P; Conti C
Antivir Chem Chemother; 2003 Jul; 14(4):195-203. PubMed ID: 14582848
[TBL] [Abstract][Full Text] [Related]
9. Antirhinovirus compound 44,081 R.P. inhibits virus uncoating.
Alarcon B; Zerial A; Dupiol C; Carrasco L
Antimicrob Agents Chemother; 1986 Jul; 30(1):31-4. PubMed ID: 3019236
[TBL] [Abstract][Full Text] [Related]
10. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.
Zhang Y; Simpson AA; Ledford RM; Bator CM; Chakravarty S; Skochko GA; Demenczuk TM; Watanyar A; Pevear DC; Rossmann MG
J Virol; 2004 Oct; 78(20):11061-9. PubMed ID: 15452226
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.
Zalman LS; Brothers MA; Dragovich PS; Zhou R; Prins TJ; Worland ST; Patick AK
Antimicrob Agents Chemother; 2000 May; 44(5):1236-41. PubMed ID: 10770757
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of the antiviral compound MDL 20,610.
Kenny MT; Torney HL; Dulworth JK
Antiviral Res; 1988 Jul; 9(4):249-61. PubMed ID: 2849377
[TBL] [Abstract][Full Text] [Related]
13. A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions.
Al-Nakib W; Tyrrell DA
Antiviral Res; 1987 Nov; 8(4):179-87. PubMed ID: 2833156
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides.
Ninomiya Y; Shimma N; Ishitsuka H
Antiviral Res; 1990 Feb; 13(2):61-74. PubMed ID: 2160796
[TBL] [Abstract][Full Text] [Related]
15. 9-Benzyl-6-(dimethylamino)-9H-purines with antirhinovirus activity.
Kelley JL; Linn JA; Krochmal MP; Selway JW
J Med Chem; 1988 Oct; 31(10):2001-4. PubMed ID: 2845083
[TBL] [Abstract][Full Text] [Related]
16. A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program.
Andries K; Dewindt B; Snoeks J; Willebrords R; Stokbroekx R; Lewi PJ
Antiviral Res; 1991 Oct; 16(3):213-25. PubMed ID: 1666824
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives.
Conti C; Desideri N
Bioorg Med Chem; 2009 May; 17(10):3720-7. PubMed ID: 19398344
[TBL] [Abstract][Full Text] [Related]
18. Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives.
Garozzo A; Cutrì CC; Castro A; Tempera G; Guerrera F; Sarvà MC; Geremia E
Antiviral Res; 2000 Mar; 45(3):199-210. PubMed ID: 10771083
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
20. Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization.
Andries K; Dewindt B; Snoeks J; Willebrords R
Arch Virol; 1989; 106(1-2):51-61. PubMed ID: 2548460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
